CureVac (CVAC) shares were up 32% in recent Thursday premarket activity after the company and BioNTech (BNTX) said they signed an agreement under which BioNTech will acquire CureVac in an all-stock deal.
Liminatus Pharma (LIMN) stock was 26% higher, shaving Wednesday's loss.
Klotho Neurosciences (KLTO) shares were 19% higher, erasing the previous session's fall.
Oracle (ORCL) stock was 9% higher, a day after the company reported higher fiscal Q4 non-GAAP earnings and revenue.